The influence of platelet-rich fibrin combined with hydroxychloroquine on the inflammatory response; bone metabolism; and cell differentiation ability in temporomandibular joint osteoarthritis.
{"title":"The influence of platelet-rich fibrin combined with hydroxychloroquine on the inflammatory response; bone metabolism; and cell differentiation ability in temporomandibular joint osteoarthritis.","authors":"Yuhan Zhao, Hongwei Dai","doi":"10.5937/jomb0-60052","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>This study aims to explore the regulatory effects of platelet-rich fibrin (PRF) on serum inflammatory response, bone metabolic balance and cell differentiation ability in patients with temporomandibular joint osteoarthritis (TMJ-OA) at the molecular level.</p><p><strong>Methods: </strong>Sixty patients were randomly divided into Group A and Group B (30 cases in each group). Group A was treated with meloxicam dispersible combined with hydrox-ychloroquine sulfate (HCQ); Group B was supplemented with autologous PRF intra-articular injection on the basis of Group A. Fasting venous blood was collected before treat-ment and 3 months after treatment. Inflammatory and bone metabolism markers such as IL-ip, IL-6, TNF-a, OPG, OPN, ALP and Runx2 were detected by e L iSA, and coagulation indicators such as A PTT and PT were deter-mined by an automatic coagulation analyzer.</p><p><strong>Results: </strong>After treatment, the inflammatory factors (IL-ip, IL-6, TNF-a) in both groups decreased significantly, but the decrease in group B was more significant (P< 0.05). Bone metabolism indicators showed that the improvement in group B was significantly better than that in group A (P< 0.05). Among the cell differentiation-related factors, the expression levels of Runx2, TGF-pi and Sox9 in group B were significantly increased compared with those before treatment (P< 0.05), and were higher than those in group A (P< 0.05).</p><p><strong>Conclusions: </strong>The use of PRF can optimize the therapeutic effect of TMJ-OA, improve inflammatory responses, promote cell differentiation and improve coagulation function parameters.</p>","PeriodicalId":16175,"journal":{"name":"Journal of Medical Biochemistry","volume":"45 3","pages":"586-593"},"PeriodicalIF":1.9000,"publicationDate":"2026-03-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13596861/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Medical Biochemistry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.5937/jomb0-60052","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: This study aims to explore the regulatory effects of platelet-rich fibrin (PRF) on serum inflammatory response, bone metabolic balance and cell differentiation ability in patients with temporomandibular joint osteoarthritis (TMJ-OA) at the molecular level.
Methods: Sixty patients were randomly divided into Group A and Group B (30 cases in each group). Group A was treated with meloxicam dispersible combined with hydrox-ychloroquine sulfate (HCQ); Group B was supplemented with autologous PRF intra-articular injection on the basis of Group A. Fasting venous blood was collected before treat-ment and 3 months after treatment. Inflammatory and bone metabolism markers such as IL-ip, IL-6, TNF-a, OPG, OPN, ALP and Runx2 were detected by e L iSA, and coagulation indicators such as A PTT and PT were deter-mined by an automatic coagulation analyzer.
Results: After treatment, the inflammatory factors (IL-ip, IL-6, TNF-a) in both groups decreased significantly, but the decrease in group B was more significant (P< 0.05). Bone metabolism indicators showed that the improvement in group B was significantly better than that in group A (P< 0.05). Among the cell differentiation-related factors, the expression levels of Runx2, TGF-pi and Sox9 in group B were significantly increased compared with those before treatment (P< 0.05), and were higher than those in group A (P< 0.05).
Conclusions: The use of PRF can optimize the therapeutic effect of TMJ-OA, improve inflammatory responses, promote cell differentiation and improve coagulation function parameters.
期刊介绍：
The JOURNAL OF MEDICAL BIOCHEMISTRY (J MED BIOCHEM) is the official journal of the Society of Medical Biochemists of Serbia with international peer-review. Papers are independently reviewed by at least two reviewers selected by the Editors as Blind Peer Reviews. The Journal of Medical Biochemistry is published quarterly.
The Journal publishes original scientific and specialized articles on all aspects of
clinical and medical biochemistry,
molecular medicine,
clinical hematology and coagulation,
clinical immunology and autoimmunity,
clinical microbiology,
virology,
clinical genomics and molecular biology,
genetic epidemiology,
drug measurement,
evaluation of diagnostic markers,
new reagents and laboratory equipment,
reference materials and methods,
reference values,
laboratory organization,
automation,
quality control,
clinical metrology,
all related scientific disciplines where chemistry, biochemistry, molecular biology and immunochemistry deal with the study of normal and pathologic processes in human beings.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
